210 related articles for article (PubMed ID: 34435331)
1. Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.
Kalita J; Kumar V; Parashar V; Misra UK
Mol Neurobiol; 2021 Nov; 58(11):6020-6031. PubMed ID: 34435331
[TBL] [Abstract][Full Text] [Related]
2. Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.
Kalita J; Kumar V; Misra UK; Kumar S
J Mol Neurosci; 2021 Feb; 71(2):338-346. PubMed ID: 32662046
[TBL] [Abstract][Full Text] [Related]
3. The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia.
Lee WJ; Tsai CF; Gauthier S; Wang SJ; Fuh JL
Int Psychogeriatr; 2012 Dec; 24(12):1980-7. PubMed ID: 22835209
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric manifestations of multiple sclerosis.
Diaz-Olavarrieta C; Cummings JL; Velazquez J; Garcia de la Cadena C
J Neuropsychiatry Clin Neurosci; 1999; 11(1):51-7. PubMed ID: 9990556
[TBL] [Abstract][Full Text] [Related]
5. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
6. Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging.
Su D; Zhang Z; Zhang Z; Zheng S; Yao T; Dong Y; Zhu W; Wei N; Suo Y; Liu X; Zhao H; Wang Z; Ma H; Li W; Zhou J; Lam JST; Wu T; Dusek P; Stoessl AJ; Wang X; Jing J; Feng T
Neurology; 2024 Jun; 102(12):e209478. PubMed ID: 38830145
[TBL] [Abstract][Full Text] [Related]
7. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.
Cummings JL
Neurology; 1997 May; 48(5 Suppl 6):S10-6. PubMed ID: 9153155
[TBL] [Abstract][Full Text] [Related]
8. Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.
Kalita J; Kumar V; Ranjan A; Misra UK
Neuromolecular Med; 2015 Dec; 17(4):364-72. PubMed ID: 26224517
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis.
Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
J Affect Disord; 2016 Jan; 190():264-271. PubMed ID: 26540080
[TBL] [Abstract][Full Text] [Related]
10. Clinical Spectrum, Radiological Correlation and Outcome of Movement Disorders in Wilson's Disease.
Mahale RR; Stezin A; Prasad S; Kamble N; Holla VV; Netravathi M; Yadav R; Pal PK
Tremor Other Hyperkinet Mov (N Y); 2023; 13():37. PubMed ID: 37840995
[TBL] [Abstract][Full Text] [Related]
11. A study of MRI changes in Wilson disease and its correlation with clinical features and outcome.
Ranjan A; Kalita J; Kumar S; Bhoi SK; Misra UK
Clin Neurol Neurosurg; 2015 Nov; 138():31-6. PubMed ID: 26278999
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
Shimabukuro J; Awata S; Matsuoka H
Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
[TBL] [Abstract][Full Text] [Related]
13. Frequency and imaging correlates of neuropsychiatric symptoms in Progressive Supranuclear Palsy.
Cuoco S; Ponticorvo S; Abate F; Tepedino MF; Erro R; Manara R; Di Salle G; Di Salle F; Pellecchia MT; Esposito F; Barone P; Picillo M
J Neural Transm (Vienna); 2023 Oct; 130(10):1259-1267. PubMed ID: 37535119
[TBL] [Abstract][Full Text] [Related]
14. Predictors of seizure in Wilson disease: A clinico-radiological and biomarkers study.
Kalita J; Misra UK; Kumar V; Parashar V
Neurotoxicology; 2019 Mar; 71():87-92. PubMed ID: 30583001
[TBL] [Abstract][Full Text] [Related]
15. The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study.
Brodaty H; Connors MH; Xu J; Woodward M; Ames D;
J Am Med Dir Assoc; 2015 May; 16(5):380-7. PubMed ID: 25687925
[TBL] [Abstract][Full Text] [Related]
16. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric symptoms in patients with vascular dementia in mainland China.
Jin YL; Zhang H; Gao YZ; Shu M; Xu Y; Liu X; Zhang SM; Zou CY; Cao J; Xiong RH
Transl Neurosci; 2015; 6(1):157-161. PubMed ID: 28123799
[TBL] [Abstract][Full Text] [Related]
19. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.
Hollingworth P; Hamshere ML; Moskvina V; Dowzell K; Moore PJ; Foy C; Archer N; Lynch A; Lovestone S; Brayne C; Rubinsztein DC; Lawlor B; Gill M; Owen MJ; Williams J
J Am Geriatr Soc; 2006 Sep; 54(9):1348-54. PubMed ID: 16970641
[TBL] [Abstract][Full Text] [Related]
20. Caregiver's distress related to the patient's neuropsychiatric symptoms as a function of the care-setting.
Lorenzo-López L; de Labra C; Maseda A; Lorenzo T; Agrafojo H; Rodríguez-Villamil JL; González-Abraldes I; Millán-Calenti JC
Geriatr Nurs; 2017; 38(2):110-118. PubMed ID: 27623026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
